The NEO-LET-EXE-trial: An intra-patient cross-over trial to explore the "lack of cross-resistance" between steroidal and non-steroidal aromatase inhibitors

被引：0
|
作者：
Bahrami, N.
Sauer, T.
Loeng, M.
Gravdehaug, B.
Engebretsen, S. S.
Aljabri, B.
Bemanian, V.
Lindstrom, J. C.
Luders, T.
Kristensen, V. N.
Geisler, J.
机构：
[1] Akershus Univ Hosp, Lorenskog, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Akershus Univ Hosp, Hlth Serv Res Unit, Lorenskog, Norway
来源：
CANCER RESEARCH | 2019年 / 79卷 / 04期
关键词：
D O I：
10.1158/1538-7445.SABCS18-OT1-01-01
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT1-01-01
引用
收藏
页数：2
相关论文
共 7 条
  • [1] Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
    Nazli Bahrami
    Shakila Jabeen
    Andliena Tahiri
    Torill Sauer
    Hilde Presterud Ødegård
    Stephanie Beate Geisler
    Berit Gravdehaug
    Laurens Cornelus Reitsma
    Knut Selsås
    Vessela Kristensen
    Jürgen Geisler
    Breast Cancer Research and Treatment, 2021, 190 : 435 - 449
  • [2] Lack of cross-resistance between non-steroidal and steroidal aromatase inhibitors in breast cancer patients: the potential role of the adipokine leptin
    Bahrami, Nazli
    Jabeen, Shakila
    Tahiri, Andliena
    Sauer, Torill
    Odegard, Hilde Presterud
    Geisler, Stephanie Beate
    Gravdehaug, Berit
    Reitsma, Laurens Cornelus
    Selsas, Knut
    Kristensen, Vessela
    Geisler, Jurgen
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 190 (03) : 435 - 449
  • [3] A QUALITATIVE SYSTEMATIC REVIEW OF THE EVIDENCE BASE FOR NON CROSS-RESISTANCE BETWEEN STEROIDAL AND NON-STEROIDAL AROMATASE INHIBITORS (AIS) IN METASTATIC BREAST CANCER
    Chakrabarti, J.
    Beresford, M.
    Tumur, I.
    Barden, J.
    Rao, N.
    Makris, A.
    ANNALS OF ONCOLOGY, 2010, 21 : 107 - 107
  • [4] The NEOLETEXE trial: a neoadjuvant cross-over study exploring the lack of cross resistance between aromatase inhibitors
    Bahrami, Nazli
    Sauer, Torill
    Engebretsen, Siri
    Aljabri, Belal
    Bemanian, Vahid
    Lindstrom, Jonas
    Luders, Torben
    Kristensen, Vessela
    Lorentzen, Annika
    Loeng, Marie
    Odegard, Hilde Presterud
    Kvaloy, Jan Oyvind
    Vestol, Ingeborg Berge
    Geisler, Stephanie Beate
    Gravdehaug, Berit
    Gundersen, Joanna Majak
    Geisler, Jurgen
    FUTURE ONCOLOGY, 2019, 15 (32) : 3675 - 3682
  • [5] A Qualitative Systematic Review of the Evidence Base for Non-cross-resistance between Steroidal and Non-steroidal Aromatase Inhibitors in Metastatic Breast Cancer
    Beresford, M.
    Tumur, I.
    Chakrabarti, J.
    Barden, J.
    Rao, N.
    Makris, A.
    CLINICAL ONCOLOGY, 2011, 23 (03) : 209 - 215
  • [6] Time-course DNA and RNA profiling of tumors from intra-patient cross-over trial of sequential use of aromatase inhibitors
    Vaske, C. J.
    Parulkar, R.
    Bahrami, N.
    Sauer, T.
    Loeng, M.
    Gravdehaug, B.
    Aljabri, B.
    Bemanian, V.
    Lindstrom, J.
    Luders, T.
    Kristensen, V.
    Geisler, J.
    CANCER RESEARCH, 2019, 79 (04)
  • [7] Clinical trial: the effects of a probiotic mixture on non-steroidal anti-inflammatory drug enteropathy - a randomized, double-blind, cross-over, placebo-controlled study
    Montalto, M.
    Gallo, A.
    Curigliano, V.
    D'Onofrio, F.
    Santoro, L.
    Covino, M.
    Dalvai, S.
    Gasbarrini, A.
    Gasbarrini, G.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2010, 32 (02) : 209 - 214
1